Logo image of NCA

NUVEEN CALIFORNIA MUNI VAL (NCA) Stock Price, Quote, News and Overview

NYSE:NCA - New York Stock Exchange, Inc. - US67062C1071 - Currency: USD

8.39  -0.01 (-0.12%)

Fundamental Rating

3

Overall NCA gets a fundamental rating of 3 out of 10. We evaluated NCA against 0 industry peers in the Unkown industry. NCA has a great financial health rating, but its profitability evaluates not so good. NCA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

NCA had negative earnings in the past year.
NCA had a negative operating cash flow in the past year.
In multiple years NCA reported negative net income over the last 5 years.
In multiple years NCA reported negative operating cash flow during the last 5 years.
NCA Yearly Net Income VS EBIT VS OCF VS FCFNCA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

The 3 year average ROIC (2.55%) for NCA is below the current ROIC(2.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.53%
ROE -8.57%
ROIC 2.84%
ROA(3y)-3.18%
ROA(5y)0.92%
ROE(3y)-3.19%
ROE(5y)0.93%
ROIC(3y)2.55%
ROIC(5y)2.55%
NCA Yearly ROA, ROE, ROICNCA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

In the last couple of years the Operating Margin of NCA has remained more or less at the same level.
In the last couple of years the Gross Margin of NCA has remained more or less at the same level.
Industry RankSector Rank
OM 86.87%
PM (TTM) N/A
GM 99.76%
OM growth 3Y0.26%
OM growth 5Y0%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.04%
GM growth 5Y0.02%
NCA Yearly Profit, Operating, Gross MarginsNCA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200 300

More info and screens

7

2. Health

2.1 Basic Checks

NCA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NCA has more shares outstanding
NCA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NCA Yearly Shares OutstandingNCA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
NCA Yearly Total Debt VS Total AssetsNCA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

NCA has an Altman-Z score of 139.20. This indicates that NCA is financially healthy and has little risk of bankruptcy at the moment.
NCA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 139.2
ROIC/WACCN/A
WACCN/A
NCA Yearly LT Debt VS Equity VS FCFNCA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 4.08 indicates that NCA has no problem at all paying its short term obligations.
NCA has a Quick Ratio of 4.08. This indicates that NCA is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.08
Quick Ratio 4.08
NCA Yearly Current Assets VS Current LiabilitesNCA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

NCA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1875.00%.
The Revenue has been growing slightly by 4.20% in the past year.
The Revenue has been growing slightly by 0.61% on average over the past years.
EPS 1Y (TTM)-1875%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)4.2%
Revenue growth 3Y4.27%
Revenue growth 5Y0.61%
Sales Q2Q%7.08%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCA Yearly Revenue VS EstimatesNCA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NCA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NCA Price Earnings VS Forward Price EarningsNCA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCA Per share dataNCA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

NCA has a Yearly Dividend Yield of 3.82%.
Compared to an average S&P500 Dividend Yield of 2.40, NCA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.82%

5.2 History

NCA has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of NCA decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
NCA Yearly Dividends per shareNCA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of NCA are negative and hence is the payout ratio. NCA will probably not be able to sustain this dividend level.
DP-40.28%
EPS Next 2YN/A
EPS Next 3YN/A
NCA Yearly Income VS Free CF VS DividendNCA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

More info and screens

NUVEEN CALIFORNIA MUNI VAL

NYSE:NCA (5/29/2025, 8:04:00 PM)

8.39

-0.01 (-0.12%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-03 2025-05-03
Earnings (Next)11-08 2025-11-08
Inst Owners23.14%
Inst Owner Change32.47%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap277.79M
Analysts81.43
Price TargetN/A
Short Float %0.22%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield 3.82%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-40.28%
Div Incr Years2
Div Non Decr Years2
Ex-Date05-15 2025-05-15 (0.029)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.98
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS0.38
BVpS9.21
TBVpS9.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.53%
ROE -8.57%
ROCE 3.6%
ROIC 2.84%
ROICexc 2.86%
ROICexgc 2.86%
OM 86.87%
PM (TTM) N/A
GM 99.76%
FCFM N/A
ROA(3y)-3.18%
ROA(5y)0.92%
ROE(3y)-3.19%
ROE(5y)0.93%
ROIC(3y)2.55%
ROIC(5y)2.55%
ROICexc(3y)2.56%
ROICexc(5y)2.56%
ROICexgc(3y)2.57%
ROICexgc(5y)2.56%
ROCE(3y)3.22%
ROCE(5y)3.23%
ROICexcg growth 3Y5.42%
ROICexcg growth 5Y-0.55%
ROICexc growth 3Y5.41%
ROICexc growth 5Y-0.56%
OM growth 3Y0.26%
OM growth 5Y0%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.04%
GM growth 5Y0.02%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.08
Quick Ratio 4.08
Altman-Z 139.2
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1875%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.2%
Revenue growth 3Y4.27%
Revenue growth 5Y0.61%
Sales Q2Q%7.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.98%
EBIT growth 3Y4.54%
EBIT growth 5Y0.61%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1702.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1702.07%
OCF growth 3YN/A
OCF growth 5YN/A